Blue Lake Biotechnology is developing intranasal vaccines that harness the full breadth of the immune system to keep people healthy, prevent serious infectious diseases, and protect the lives of vulnerable populations
Blue Lake is developing intranasal vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.
Our vaccines have the potential to block the transmission of viral infections and reduce their spread.
Our platform enables us to make potent yet well-tolerated vaccines that are easy to administer, easy to transport, and easy to manufacture.
